• Expansion Brings Full Scale Production Capability

News & Views

Expansion Brings Full Scale Production Capability

Jan 18 2016

Since installation of bulk production capability for its colloidal gold nanoparticle products, Innova Biosciences, a specialist provider of bioconjugation products and services can now offer support for any scale of operation, including the largest players in the diagnostics field.

The Company has also taken a further 2500 sq ft of office space at the South Cambridge Business Park, which will be occupied by its sales and marketing team.

Dr Nick Gee, CEO of Innova Biosciences, commented: “Innova is committed to supporting all customers with the same high level of service and consistency in quality, from academic researchers through to bulk manufacturing scientists.”

Gold nanoparticles are used in many applications such as lateral flow point-of-care assays, microscopy, flow cytometry, Raman spectroscopy and dynamic light scattering.


Digital Edition

Lab Asia 31.2 April 2024

April 2024

In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...

View all digital editions

Events

Microbiology Society Annual Conference 2024

Apr 08 2024 Edinburgh 2024

analytica 2024

Apr 09 2024 Munich, Germany

ChemBio Finland 2024

Apr 10 2024 Helsinki, Finland

Analytica Anacon India & IndiaLabExpo

Apr 15 2024 Mumbai, India

Analitika Expo 2024

Apr 16 2024 Moscow, Russia

View all events